Showing all 23 results
Amlodipine besylate with Losartan potassium Tablets
FreeAmlodipine Tablets IP 5 mg
Each Uncoated tablet contains :
Amlodipine Besylate IP
Eq to Amlodipine 5 mgAmlodipine Tablets IP 10 mg
Each Uncoated Tablet Contains :
Amlodipine Besylate IP
Eq To Amlodipine 10 mgAmlodipine Besylate Tablets IP 2.5 mg
Each uncoated tablet contains :
Amlodipine Besylate IP
Eq. To Amlodipine 2.5 mgAmlodipine Besylate Tablets IP 2.5 mg
Each Film Coated Tablet Contains:
Amlodipine Besylate IP
eq. To Amlodipine 2.5 mgAmlodipine Besylate Tablets IP 5 mg
Each Film Coated Tablet Contains:
Amlodipine Besylate IP
eq. To Amlodipine 5 mgAMLODIPINE & ENALAPRIL MALEATE TABLET
Each Film Coated Tablet Contains :
Amlodipine Besylate
Eq. To Amlodipine 5 mg
Enalapril Maleate 5 mg
Excipients q.sAMLODIPINE & LISINOPRIL TABLET
Each Film Coated Tablet Contains :
Amlodipine Besylate
Eq. To Amlodipine 5 mg
Lisinopril dihydrate
Eq. To Lisinopril 5 mg
Excipients q.sTRIPPLEACE AMLODIPINE -10 / AMLODIPINE
TABLETS 10 MG
Each uncoated tablet contains:
Amlodipine Besilate BP
Equivalent to Amlodipine 10 mg
Excipients Q.S.Usage: – Treat high blood pressure
Category: – Hypertensive / Cardiac Drugs
Therapeutic category: – hypertensive, Cardiovascular Agent,
Amlodipine With Enalapril maleate Tablets
FreeAmlodipine Tablets IP 5 mg
Each Uncoated tablet contains :
Amlodipine Besylate IP
Eq to Amlodipine 5 mgAmlodipine Tablets IP 10 mg
Each Uncoated Tablet Contains :
Amlodipine Besylate IP
Eq To Amlodipine 10 mgAmlodipine Besylate Tablets IP 2.5 mg
Each uncoated tablet contains :
Amlodipine Besylate IP
Eq. To Amlodipine 2.5 mgAmlodipine Besylate Tablets IP 2.5 mg
Each Film Coated Tablet Contains:
Amlodipine Besylate IP
eq. To Amlodipine 2.5 mgAmlodipine Besylate Tablets IP 5 mg
Each Film Coated Tablet Contains:
Amlodipine Besylate IP
eq. To Amlodipine 5 mgAMLODIPINE & ENALAPRIL MALEATE TABLET
Each Film Coated Tablet Contains :
Amlodipine Besylate
Eq. To Amlodipine 5 mg
Enalapril Maleate 5 mg
Excipients q.sAMLODIPINE & LISINOPRIL TABLET
Each Film Coated Tablet Contains :
Amlodipine Besylate
Eq. To Amlodipine 5 mg
Lisinopril dihydrate
Eq. To Lisinopril 5 mg
Excipients q.sTRIPPLEACE AMLODIPINE -10 / AMLODIPINE
TABLETS 10 MG
Each uncoated tablet contains:
Amlodipine Besilate BP
Equivalent to Amlodipine 10 mg
Excipients Q.S.Usage: – Treat high blood pressure
Category: – Hypertensive / Cardiac Drugs
Therapeutic category: – hypertensive, Cardiovascular Agent,
Atenolol with Chlorthalidone tablets.
Freetenolol Tablets IP 25 mg Each Uncoated Tablet
contains :- Atenolol IP 25 mg
Excipients – QSAtenolol Tablets IP 50 mg
Each Uncoated Tablet contains :
Atenolol IP 50 mg
Excipients q.sOtenol 50
Atenolol Tablets BP
Each Uncoated tablet contains :
Atenolol BP 50 mgOtenol
Atenolol Tablets BP
Each Uncoated tablet contains :
Atenolol BP 100 mgUsage: – Treat high blood pressure and irregular heartbeat
Category: – Hypertensive Cardiac drugs
Therapeutic category: – Cardiovascular Agent,Anti hypertensive
Chlorthalidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the stability of the micronized active ingredient.
Active Ingredient Strength Primary Clinical Function Chlorthalidone USP/BP 6.25 mg / 12.5 mg The Contemporary Starting Dose: Highly preferred for modern “Low-Dose” hypertension therapy to maximize pressure control while minimizing electrolyte loss. Chlorthalidone USP/BP 25 mg The High-Potency Payload: Utilized for resistant hypertension or the management of edema associated with heart failure or hepatic cirrhosis. Excipients Microcrystalline Cellulose / Colloidal Silicon Dioxide / Magnesium Stearate / Pregelatinized Starch Diluent / Glidant / Lubricant / Binder (Engineered specifically utilizing Micronized API Technology to ensure absolute uniformity in the 6.25mg and 12.5mg ultra-low-dose tablets, guaranteeing consistent renal response across every batch). CILNIDIPINE & TELMISARTAN TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bilayer or Co-Processed Tablet, packed exclusively in secure, high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive Telmisartan and light-sensitive Cilnidipine.
Active Ingredient Strength Primary Clinical Function Telmisartan USP/Ph.Eur. 40 mg The Hormonal Stabilizer: Blocks the RAAS system to provide 24-hour systemic pressure control and metabolic benefits (PPAR-gamma activation). Cilnidipine USP/Ph.Eur. 10 mg The Vascular Relaxant: Provides immediate N-type and L-type calcium channel blockade to lower peripheral resistance without edema. Excipients Meglumine / Sorbitol / Sodium Hydroxide / Magnesium Stearate / Titanium Dioxide (Opaque Coating) Solubilizer / Diluent / PH Modifier / Light Shield (Engineered specifically utilizing Alkaline Matrix Solubilization. Telmisartan requires a highly alkaline environment to dissolve, while Cilnidipine is light-sensitive. Our bilayer technology ensures each API is released at its peak kinetic window). Clindipine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Light-Shielded Cardiovascular Tablet, packed exclusively in highly secure, opaque Alu-Alu blister strips to ensure the absolute chemical stability of the highly photosensitive active ingredient.
Active Ingredient Strength Primary Clinical Function Cilnidipine USP/Ph.Eur. 5 mg The Geriatric & Titration Anchor: The definitive starting dose utilized for elderly patients or those with mild essential hypertension to prevent sudden hypotensive episodes. Cilnidipine USP/Ph.Eur. 10 mg The Global Maintenance Standard: The standardized daily therapeutic payload utilized for the vast majority of adult patients requiring chronic 24-hour blood pressure control. Cilnidipine USP/Ph.Eur. 20 mg The Severe Refractory Macrodose: Utilized strictly for severe, uncontrolled hypertension where the 10mg dose has failed to achieve target blood pressure metrics. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Croscarmellose Sodium / Hypromellose / Magnesium Stearate / Opaque Polymeric Film (Titanium Dioxide base) Diluent / Densifier / Superdisintegrant / Binder / Lubricant / Protective Light Shield (Engineered specifically utilizing a dense, titanium dioxide-heavy film coat. Cilnidipine is intensely sensitive to UV and visible light; this opaque coating guarantees 100% of the active molecule survives to reach the patient’s systemic circulation) *Pack Sizes: 10×10 Opaque Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Losartan Potassium Amlodipine besylate Tablet
FreeLosartan potassium and amlodipine besylate tablets are a combination antihypertensive medication that includes an angiotensin II receptor blocker (ARB) and a calcium channel blocker (CCB).
Losartan Potassium Hydrochlorothiazide Tablets
FreeLosartan potassium and hydrochlorothiazide tablets are a combination medication containing an angiotensin II receptor blocker (ARB) and a thiazide diuretic to treat high blood pressure.
Losartan Tablets
FreeLosartan Potassium Tablets IP 25 mg
Each Film Coated Tablets Contains:
Losartan Potassium IP 25 mgLosartan Potassium Tablet IP 50 mg
Each Film Coated Tabet Contains :
Losartan Potasium IP 50 mgLOSARTAN POTASSIUM & HYDROCHLOROTHIAZIDE TABLETS IP
Each Film Coated Tablet Contains :: Losartan potassium IP 50 mg
Hydrochlorothiazide IP 12.5 mg – Excipients – QSLOSARTAN POTASSIUM & AMLODIPINE TABLET IP
Each Film Coated Tablet Contains :
Losartan potassium IP 50mg
Amlodipine Besylate IP Eq. To Amlodipine 5 mg
Excipients q.sUsage: – Treat high blood pressure (hypertension)
Category: – Anti Cardiovascular Drugs
Therapeutic category: – Cardiovascular Agent, Antihypertensive
Metoprolol & Amlodipin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the combined molecules.
Active Ingredient Strength Primary Clinical Function Metoprolol (as Tartrate/Succinate ER) Ph.Eur./USP 25 mg / 50 mg Cardioselective Base: Reduces heart rate, cardiac workload, and neutralizes CCB-induced reflex tachycardia. Amlodipine (as Besylate) Ph.Eur./USP 5 mg Calcium Channel Blocker (CCB): Forces profound peripheral arterial vasodilation, dropping severe blood pressure and relieving coronary spasms. Excipients Microcrystalline Cellulose / Dibasic Calcium Phosphate / Crospovidone / Magnesium Stearate / Premium Opadry Film / Iron Oxide Colors Diluent / Stabilizing Buffer / Superdisintegrant / Lubricant (Engineered specifically using bilayer press technology to physically separate the slightly acidic Metoprolol salt from the basic Amlodipine, preventing destructive chemical cross-talk) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Nebivolol & Telmisartan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Bilayer Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic and pH-sensitive active ingredients.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 2.5 mg / 5 mg Nitric Oxide Donating Beta-Blocker: Reduces cardiac workload while promoting active peripheral vasodilation and preserving sexual function. Telmisartan Ph.Eur./USP 40 mg Metabolic ARB: Provides sustained 24-hour RAAS blockade and improves cellular insulin sensitivity (PPAR-γ modulation). Excipients Meglumine / Sodium Hydroxide / Microcrystalline Cellulose / Povidone K30 / Polysorbate 80 / Magnesium Stearate Alkalizing Agents (Meglumine) / Diluent / Binder / Surfactant (Engineered specifically to create a hyper-alkaline micro-environment for Telmisartan dissolution, physically isolated from the Nebivolol layer to prevent cross-degradation) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Nebivolol Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dual-Active Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the active ingredients.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 5 mg Cardioselective & Vasodilatory Base: Reduces cardiac workload and provides active Nitric Oxide-driven peripheral vasodilation. Hydrochlorothiazide (HCTZ) Ph.Eur./USP 12.5 mg / 25 mg Thiazide Diuretic Driver: Forces the excretion of excess sodium and water, massively amplifying the blood-pressure-lowering effect of the beta-blocker. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Polysorbate 80 / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Wetting Surfactant / Moisture-Barrier Coating (Engineered specifically to protect the highly delicate racemic Nebivolol balance while ensuring rapid, synchronized gastric dissolution of the diuretic) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Nebivolol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Low-Dose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hydrochloride salt.
Active Ingredient Strength Primary Clinical Function Nebivolol (as HCl) Ph.Eur./USP 2.5 mg / 5 mg Global Hypertension Standard: Base therapeutic unit for the continuous, highly tolerated management of essential hypertension. Nebivolol (as HCl) Ph.Eur./USP 10 mg / 20 mg Advanced Cardiac Standard: High-dose maintenance therapy for refractory hypertension and specialized heart failure protocols. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Hypromellose / Polysorbate 80 / Magnesium Stearate Diluent / Superdisintegrant / Wetting Agent / Lubricant (Engineered specifically to ensure rapid, predictable gastric dissolution while protecting the delicate racemic balance of the API) *Pack Sizes: 10×10 Blisters or 28/30-Tablet Calendar Packs (Optimized specifically for strict, high-compliance chronic cardiology dispensing regimens).
Olmesartan + Amlodipine + Hydroclorthiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered, API-Segregated Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of all three active ingredients across their entire shelf life.
Active Ingredient Strength Primary Clinical Function Olmesartan Medoxomil Ph.Eur./USP 20 mg / 40 mg ARB Base: Blocks the renin-angiotensin-aldosterone system (RAAS) and provides critical diabetic renoprotection. Amlodipine (as Besylate) Ph.Eur./USP 5 mg / 10 mg CCB Vasodilator: Forces profound, sustained peripheral arterial relaxation. Hydrochlorothiazide (HCTZ) Ph.Eur./USP 12.5 mg / 25 mg Diuretic Volume Controller: Flushes excess sodium/water and massively amplifies the efficacy of the ARB component. Excipients Silicified Microcrystalline Cellulose / Pregelatinized Starch / Croscarmellose Sodium / Magnesium Stearate / Opadry Protective Film Moisture-Scavenging Diluent / Binder / Superdisintegrant / Premium Film-Coating (Engineered specifically to physically isolate the highly sensitive Olmesartan ester from the alkaline Amlodipine salt to prevent cross-degradation) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Olmesartan Medoxomil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly volatile ester prodrug.
Active Ingredient Strength Primary Clinical Function Olmesartan Medoxomil Ph.Eur./USP 20 mg Initiation / Global Standard: Standard adult starting and maintenance dose for the continuous control of essential hypertension. Olmesartan Medoxomil Ph.Eur./USP 40 mg Severe Refractory Standard: Maximum adult maintenance dose for patients requiring further reduction in blood pressure. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Hydroxypropyl Cellulose / Magnesium Stearate / Titanium Dioxide Low-Moisture Diluent / Binder / Lubricant / Premium Moisture-Barrier Film-Coating (Engineered specifically to lock out ambient humidity and prevent the premature hydrolysis of the medoxomil group prior to ingestion) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
Perindopril Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips equipped with active desiccants to ensure the absolute chemical stability of the highly degradable Erbumine salt.
Active Ingredient Strength Primary Clinical Function Perindopril Erbumine Ph.Eur./USP 2 mg Initiation Standard: Base titration dose for elderly patients or those with severe heart failure/renal impairment to prevent sudden hypotension. Perindopril Erbumine Ph.Eur./USP 4 mg Hypertension Standard: Standard adult maintenance dose for the continuous control of essential hypertension. Perindopril Erbumine Ph.Eur./USP 8 mg Cardiovascular Risk Standard: Maximum maintenance dose for profound risk reduction in patients with stable coronary artery disease. Excipients Microcrystalline Cellulose / Lactose Anhydrous / Hydrophobic Colloidal Silica / Magnesium Stearate Diluent / Alkaline Stabilizer / Moisture Scavenger / Lubricant (Engineered specifically to create a hyper-dry internal tablet matrix that absolutely prevents hydrolytic cyclization of the API) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict 30-day chronic cardiology dispensing regimens).
RAMIPRIL & HYDROCLORTHIAZIDE TABLETS
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet or Capsule, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Ramipril Ph.Eur./USP 5 mg (or 2.5 mg / 10 mg) ACE inhibition for vasodilation, RAAS blockade, and critical potassium retention. Hydrochlorothiazide Ph.Eur./USP 12.5 mg / 25 mg Global Clinical Standard: Thiazide diuretic for sodium excretion and sustained blood volume reduction. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Sodium Bicarbonate / Hypromellose / Magnesium Stearate Diluent / Superdisintegrant / Alkaline Stabilizing Agent (Engineered specifically to protect Ramipril from acidic degradation and moisture-induced cyclization) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance 30-day chronic cardiology dispensing regimens).
Ramipril and Amlodipine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Capsule or Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly degradable Ramipril molecule.
Active Ingredient Strength Primary Clinical Function Ramipril Ph.Eur./USP 5 mg / 10 mg ACE inhibition for vasodilation, neurohormonal blockade, and venous pressure equalization. Amlodipine (as Besilate) Ph.Eur./USP 5 mg / 10 mg Global Clinical Standard: Sustained CCB for profound, 24-hour arterial vasodilation. Excipients Microcrystalline Cellulose / Crospovidone / Sodium Stearyl Fumarate / Hypromellose / Iron Oxide Red Diluent / Superdisintegrant / Alkaline Stabilizing Lubricant (Engineered to protect Ramipril from acidic degradation and moisture) *Pack Sizes: 10×10 Alu-Alu Blisters or 3×10 Unit-Dose Blisters (Optimized specifically for strict, high-compliance 30-day chronic cardiology dispensing regimens).
Telmisartan 40Mg + Chlorthalidone 6.25Mg Tablet
FreeA Telmisartan 40mg + Chlorthalidone 6.25mg tablet is a fixed-dose combination antihypertensive medication used to treat high blood pressure (hypertension) when a single medicine is not effective enough.
Telmisartan 40mg and Metoprolol 25mg Tablets
FreeA Telmisartan 40mg + Metoprolol 25mg tablet is a combination antihypertensive medication used to manage high blood pressure (hypertension).
Telmisartan 50Mg + Metoprolol Succinate Entric Coated 40Mg Tablets
FreeA Telmisartan 40mg + Metoprolol Succinate 50mg (often referred to as enteric-coated or extended-release) tablet is a fixed-dose combination antihypertensive medication. It is primarily used to treat hypertension (high blood pressure) when a single medicine is insufficient, as well as to reduce the risk of heart attack and stroke.
Telmisartan Tablets
FreeTELMIZIDE TABLETS
Telmisartan With Hydrochlorthiazide Tablet
Each Film Coated Tablet contains:
Telmisartan 40 mg
Hydrochlorthiazide IP 12.5 mgUsage: – treat high blood pressure (hypertension)
Category: – Anti Cardiovascular drugs
Therapeutic category: – Cardiovascular Agent, Antihypertensive
Telmisartan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips. The formulation utilizes specialized alkalizing agents to ensure the highly insoluble API rapidly dissolves in the gastrointestinal tract.
Active Ingredient Strength Primary Clinical Use Telmisartan USP/BP/Ph.Eur. 20 mg Initiation / Hepatic Impairment: Low-dose titration for sensitive or hepatically compromised patients. Telmisartan USP/BP/Ph.Eur. 40 mg Standard Global Dose: Once-daily maintenance therapy for essential hypertension. Telmisartan USP/BP/Ph.Eur. 80 mg Maximum CV Protection: High-dose therapy for severe hypertension and mandated cardiovascular risk reduction. Excipients Meglumine / Sodium Hydroxide / Povidone / Magnesium Stearate Alkalizing Stabilizer / Binder / Lubricant (Engineered to prevent API crystallization and ensure rapid absorption)
